Skip to main content
An official website of the United States government
Español
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Afinitor Disperz

(uh-FIH-nih-tor DIS-perz)
A drug that contains the active ingredient everolimus and is used to treat a type of benign brain tumor called subependymal giant cell astrocytoma and certain types of seizures in patients who have tuberous sclerosis. Afinitor Disperz blocks a protein involved in cell division, which may help keep abnormal cells from growing. It may also prevent the growth of new blood vessels that tumors need to grow. It may also help prevent or treat seizures in some patients. Afinitor Disperz is a type of kinase inhibitor and a type of angiogenesis inhibitor.
More Information
Search NCI's Dictionary of Cancer Terms